596 related articles for article (PubMed ID: 7664216)
21. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
22. Cough induced by losartan with resolution after substitution with enalapril.
Dashti-Khavidaki S; Faghihi T; Ahmadi F; Khalili H
Clin Ther; 2008 Mar; 30(3):548-51. PubMed ID: 18405793
[TBL] [Abstract][Full Text] [Related]
23. Experience with angiotensin II antagonists in hypertensive patients.
Waeber B; Burnier M; Nussberger J; Brunner HR
Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S142-6. PubMed ID: 21143288
[TBL] [Abstract][Full Text] [Related]
24. Renin-angiotensin system mediators and Raynaud's phenomenon.
Wood HM; Ernst ME
Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
[TBL] [Abstract][Full Text] [Related]
25. Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension.
Motwani JG
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):72-8. PubMed ID: 12228846
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
27. The advantages of angiotensin II antagonism.
Burnier M; Waeber B; Brunner HR
J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
[TBL] [Abstract][Full Text] [Related]
28. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
29. Cough and inhibition of the renin-angiotensin system.
Karlberg BE
J Hypertens Suppl; 1993 Apr; 11(3):S49-52. PubMed ID: 8315520
[TBL] [Abstract][Full Text] [Related]
30. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group.
Lacourciére Y
Int J Clin Pract; 1999 Mar; 53(2):99-103. PubMed ID: 10344043
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.
Gales BJ; Bailey EK; Reed AN; Gales MA
Ann Pharmacother; 2010 Feb; 44(2):360-6. PubMed ID: 20086184
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
33. The renin-angiotensin system: importance in physiology and pathology.
Ferrario CM
J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S1-5. PubMed ID: 1691411
[TBL] [Abstract][Full Text] [Related]
34. [Comparison between AngII receptor antagonist and ACE inhibitor].
Fujimi K; Urata H
Nihon Rinsho; 2001 May; 59(5):999-1003. PubMed ID: 11392005
[TBL] [Abstract][Full Text] [Related]
35. Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough.
Chan P; Tomlinson B; Huang TY; Ko JT; Lin TS; Lee YS
J Clin Pharmacol; 1997 Mar; 37(3):253-7. PubMed ID: 9089428
[TBL] [Abstract][Full Text] [Related]
36. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.
Paster RZ; Snavely DB; Sweet AR; Draper RA; Goldberg AI; Soffer BA; Sweet CS
Clin Ther; 1998; 20(5):978-89. PubMed ID: 9829449
[TBL] [Abstract][Full Text] [Related]
37. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
Pylypchuk GB
Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599
[TBL] [Abstract][Full Text] [Related]
38. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
Scheen AJ
Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
[TBL] [Abstract][Full Text] [Related]
39. Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor.
Goh TC; Ong YY
Singapore Med J; 1991 Jun; 32(3):183-4. PubMed ID: 1652161
[TBL] [Abstract][Full Text] [Related]
40. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
Sanada S; Kitakaze M
Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
